19,115,370 Shares in First Trust Nasdaq Pharmaceuticals ETF $FTXH Purchased by First Trust Advisors LP

First Trust Advisors LP acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 19,115,370 shares of the company’s stock, valued at approximately $792,714,000. First Trust Advisors LP owned approximately 70.28% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Asset Dedication LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $25,000. Compass Financial Management LLC purchased a new position in First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth approximately $29,000. Harbour Investments Inc. acquired a new position in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at about $39,000. Claro Advisors Inc. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $312,000. Finally, Flagship Harbor Advisors LLC increased its holdings in First Trust Nasdaq Pharmaceuticals ETF by 50.9% during the 3rd quarter. Flagship Harbor Advisors LLC now owns 8,500 shares of the company’s stock worth $352,000 after purchasing an additional 2,868 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

FTXH opened at $41.71 on Friday. First Trust Nasdaq Pharmaceuticals ETF has a one year low of $31.54 and a one year high of $45.10. The business’s 50-day simple moving average is $42.28 and its 200-day simple moving average is $37.93. The stock has a market capitalization of $1.05 billion, a P/E ratio of 32.96 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Thursday, September 24th were paid a $0.0113 dividend. This represents a $0.05 annualized dividend and a dividend yield of 0.1%. This is a drop from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920. The ex-dividend date was Thursday, September 24th.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

(Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

Recommended Stories

Institutional Ownership by Quarter for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

Receive News & Ratings for First Trust Nasdaq Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.